Alliancebernstein L.P. Axsome Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$290 Billion
Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 45,982 shares of AXSM stock, worth $6.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,982

Previous 61,471 25.2%

Holding current value

$6.2 Million

Previous $7.17 Million 33.05%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$95.65 - $116.49 $1.48 Million - $1.8 Million	-15,489 Reduced 25.2%	45,982 $4.8 Million
Q1 2025 May 15, 2025	BUY	$80.05 - $137.75 $1.19 Million - $2.05 Million	14,881 Added 31.94%	61,471 $7.17 Million
Q4 2024 Feb 12, 2025	SELL	$83.08 - $100.49 $6.51 Million - $7.88 Million	-78,388 Reduced 62.72%	46,590 $3.94 Million
Q3 2024 Nov 14, 2024	SELL	$78.93 - $95.84 $3.46 Million - $4.2 Million	-43,784 Reduced 25.94%	124,978 $11.2 Million
Q2 2024 Aug 14, 2024	BUY	$65.72 - $80.5 $5.82 Million - $7.13 Million	88,608 Added 110.55%	168,762 $13.6 Million
Q1 2024 May 14, 2024	BUY	$69.39 - $97.64 $2.7 Million - $3.79 Million	38,864 Added 94.12%	80,154 $6.4 Million
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $40,857 - $48,503	590 Added 1.45%	41,290 $2.89 Million
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $15,217 - $32,725	700 Added 1.75%	40,700 $1.56 Million
Q1 2022 May 13, 2022	BUY	$23.7 - $41.39 $80,580 - $140,726	3,400 Added 9.29%	40,000 $1.66 Million
Q4 2021 Feb 14, 2022	SELL	$30.7 - $43.36 $128,940 - $182,112	-4,200 Reduced 10.29%	36,600 $1.38 Million
Q2 2021 Jul 30, 2021	SELL	$50.63 - $73.5 $30.4 Million - $44.1 Million	-599,585 Reduced 93.63%	40,800 $2.75 Million
Q1 2021 May 06, 2021	BUY	$55.91 - $81.44 $2.38 Million - $3.47 Million	42,587 Added 7.12%	640,385 $36.3 Million
Q4 2020 Feb 08, 2021	BUY	$66.31 - $86.52 $3.68 Million - $4.8 Million	55,525 Added 10.24%	597,798 $48.7 Million
Q3 2020 Nov 12, 2020	BUY	$68.34 - $85.84 $5.88 Million - $7.39 Million	86,071 Added 18.87%	542,273 $38.6 Million
Q2 2020 Aug 13, 2020	BUY	$49.87 - $98.69 $7.8 Million - $15.4 Million	156,411 Added 52.17%	456,202 $37.5 Million
Q1 2020 May 14, 2020	BUY	$41.2 - $101.31 $1.32 Million - $3.24 Million	31,966 Added 11.94%	299,791 $17.6 Million
Q4 2019 Feb 18, 2020	SELL	$16.71 - $106.24 $8.33 Million - $52.9 Million	-498,354 Reduced 65.04%	267,825 $27.7 Million
Q3 2019 Nov 14, 2019	SELL	$20.24 - $29.16 $94,945 - $136,789	-4,691 Reduced 0.61%	766,179 $15.5 Million
Q2 2019 Aug 14, 2019	BUY	$13.46 - $25.75 $10.4 Million - $19.8 Million	770,870 New	770,870 $19.9 Million

Others Institutions Holding AXSM

# of Institutions

413

Shares Held

37.4M

Call Options Held

710K

Put Options Held

541K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $5.79B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Axsome Therapeutics, Inc. Transaction History